These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39016539)

  • 1. Phylogenomic and genomic analysis reveals unique and shared genetic signatures of
    Machado E; Vasconcellos S; Gomes L; Catanho M; Ramos J; de Carvalho L; Goldenberg T; Redner P; Caldas P; Campos C; Dalcolmo M; Lourenço MC; Lasunskaia E; Mussi V; Spinassé L; Vinhas S; Rigouts L; Cogneau S; de Rijk P; Utpatel C; Kaustova J; van der Laan T; de Neeling H; Rastogi N; Levina K; Kütt M; Mokrousov I; Zhuravlev V; Makhado N; Žolnir-Dovč M; Jankovic V; de Waard J; Sisco MC; van Soolingen D; Niemann S; de Jong BC; Meehan CJ; Suffys P
    Microb Genom; 2024 Jul; 10(7):. PubMed ID: 39016539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population genomics provides insights into the evolution and adaptation to humans of the waterborne pathogen Mycobacterium kansasii.
    Luo T; Xu P; Zhang Y; Porter JL; Ghanem M; Liu Q; Jiang Y; Li J; Miao Q; Hu B; Howden BP; Fyfe JAM; Globan M; He W; He P; Wang Y; Liu H; Takiff HE; Zhao Y; Chen X; Pan Q; Behr MA; Stinear TP; Gao Q
    Nat Commun; 2021 May; 12(1):2491. PubMed ID: 33941780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Genomic and Transcriptomic Analyses of
    Guan Q; Ummels R; Ben-Rached F; Alzahid Y; Amini MS; Adroub SA; van Ingen J; Bitter W; Abdallah AM; Pain A
    Front Cell Infect Microbiol; 2020; 10():122. PubMed ID: 32266172
    [No Abstract]   [Full Text] [Related]  

  • 4. Human pathogenic
    Fukano H; Terazono T; Hirabayashi A; Yoshida M; Suzuki M; Wada S; Ishii N; Hoshino Y
    Emerg Microbes Infect; 2021 Dec; 10(1):220-222. PubMed ID: 33467980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii.
    Wang J; McIntosh F; Radomski N; Dewar K; Simeone R; Enninga J; Brosch R; Rocha EP; Veyrier FJ; Behr MA
    Genome Biol Evol; 2015 Feb; 7(3):856-70. PubMed ID: 25716827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Insights Into the
    Jagielski T; Borówka P; Bakuła Z; Lach J; Marciniak B; Brzostek A; Dziadek J; Dziurzyński M; Pennings L; van Ingen J; Žolnir-Dovč M; Strapagiel D
    Front Microbiol; 2019; 10():2918. PubMed ID: 32010067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.
    Guo Y; Cao Y; Liu H; Yang J; Wang W; Wang B; Li M; Yu F
    Microbiol Spectr; 2022 Feb; 10(1):e0147521. PubMed ID: 35019778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogenomics reveal that Mycobacterium kansasii subtypes are species-level lineages. Description of Mycobacterium pseudokansasii sp. nov., Mycobacterium innocens sp. nov. and Mycobacterium attenuatum sp. nov.
    Tagini F; Aeby S; Bertelli C; Droz S; Casanova C; Prod'hom G; Jaton K; Greub G
    Int J Syst Evol Microbiol; 2019 Jun; 69(6):1696-1704. PubMed ID: 30950782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity.
    Machado E; Vasconcellos SEG; Cerdeira C; Gomes LL; Junqueira R; Carvalho LD; Ramos JP; Redner P; Campos CED; Caldas PCS; Gomes APCS; Goldenberg T; Montes FF; Mello FCQ; Mussi VO; Lasunskaia E; Soolingen DV; Miranda AB; Rigouts L; Jong BC; Meehan CJ; Catanho M; Suffys PN
    Mem Inst Oswaldo Cruz; 2018 Jun; 113(9):e180085. PubMed ID: 29947722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene.
    Bakuła Z; Safianowska A; Nowacka-Mazurek M; Bielecki J; Jagielski T
    Biomed Res Int; 2013; 2013():178725. PubMed ID: 24455675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character.
    van Ingen J; de Zwaan R; Dekhuijzen R; Boeree M; van Soolingen D
    J Bacteriol; 2009 Sep; 191(18):5865-7. PubMed ID: 19617365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and phenotypic characterization of
    Sous C; Frigui W; Pawlik A; Sayes F; Ma L; Cokelaer T; Brosch R
    Microbiol Spectr; 2024 Jun; 12(6):e0412623. PubMed ID: 38700329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines.
    Kwenda G; Churchyard GJ; Thorrold C; Heron I; Stevenson K; Duse AG; Marais E
    J Water Health; 2015 Mar; 13(1):190-202. PubMed ID: 25719478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Mycobacterium kansasii using a combination of loop-mediated isothermal amplification (LAMP) and lateral flow biosensors.
    Chen C; Lu J; Long B; Rao Z; Gao Y; Wang W; Gao W; Yang J; Zhang S
    Int Microbiol; 2021 Jan; 24(1):75-82. PubMed ID: 32880033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
    da Silva Telles MA; Chimara E; Ferrazoli L; Riley LW
    J Med Microbiol; 2005 Oct; 54(Pt 10):975-979. PubMed ID: 16157553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and vaccine potential of clinical isolate
    Kim H; Shin SJ
    Microbiol Spectr; 2024 Aug; 12(8):e0081924. PubMed ID: 38980025
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular characterization of Mycobacterium kansasii isolates in the State of São Paulo between 1995-1998.
    Chimara E; Giampaglia CM; Martins MC; Telles MA; Ueki SY; Ferrazoli L
    Mem Inst Oswaldo Cruz; 2004 Nov; 99(7):739-43. PubMed ID: 15654431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogeographic Analysis of Mycobacterium kansasii Isolates from Patients with M. kansasii Lung Disease in Industrialized City, Taiwan.
    Tobias Cudahy PG; Liu PC; Warren JL; Sobkowiak B; Yang C; Ioerger TR; Wu CY; Lu PL; Wang JY; Chang HH; Huang HL; Cohen T; Lin HH
    Emerg Infect Dis; 2024 Aug; 30(8):1562-1570. PubMed ID: 39043390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenicity of Mycobacterium kansasii].
    Vesenbeckh S; Wagner S; Mauch H; Roth A; Streubel A; Rüssmann H; Bauer TT; Matthiessen W; Schönfeld N
    Pneumologie; 2014 Aug; 68(8):526-31. PubMed ID: 25046682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Determinants of the
    Tagini F; Pillonel T; Bertelli C; Jaton K; Greub G
    Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33578772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.